Latest Top Picks

Stock Opinions by Rob Peets

WAIT
Interesting technology. Treatment is in early clinical trials.
DON'T BUY
Growth has not been as great as expected. Demographics for nursing facilities is too far off.
DON'T BUY
Good sales. Have to get their R&D costs down.
DON'T BUY
Has a lot of financial support, but will take a long while.
WEAK BUY
Has done reasonably well, but this year, snow has been late in their area. Reasonable.
PAST TOP PICK
(Was a top pick on Oct 22. Down 24%) Still considered a speculative buy.
PAST TOP PICK
(Was a top pick on Oct 22. Down 20%)
DON'T BUY
Doesn't see much happening in the near term.
DON'T BUY
Interesting technology. May take a long time.
DON'T BUY
Nave commercial products that are being sold in China. Still has a lot of development needed.
BUY
In a $1/1.50 range. Demand in US has been slow. Should be a reasonable growth in the next 2/3 years.
WEAK BUY
Tecnhnology soundds attractive, but work has to be done yet.
DON'T BUY
To have growth potential, new products will be needed.
DON'T BUY
Sector is exploding in urban centres, but has limits country wide.
DON'T BUY
Running short on cash.
Showing 1 to 15 of 50 entries